Copy For Citation
ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G., İBİŞ E.
CLINICAL NUCLEAR MEDICINE, vol.37, no.8, pp.755-758, 2012 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
37
Issue:
8
-
Publication Date:
2012
-
Doi Number:
10.1097/rlu.0b013e31825ae77b
-
Journal Name:
CLINICAL NUCLEAR MEDICINE
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.755-758
-
Keywords:
differentiated thyroid cancers, antithyroglobulin antibody, F-18-FDG PET/CT, SERUM THYROGLOBULIN MEASUREMENT, FOLLOW-UP, CARCINOMA, AUTOANTIBODIES, PREVALENCE, SCAN
-
Ankara University Affiliated:
Yes
Abstract
Aim: The aim of this study was to investigate the additive clinical value of F-18-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer (DTC) who have isolated increased antithyroglobulin antibody (TgAb) levels with undetectable thyroglobulin (Tg) levels and negative I-131 whole-body scintigraphy (wbs).